SEC Filing Update: #PCSA Processa Pharmaceuticals, Inc. : $2.14

Sector: Healthcare | YTD: 🔽 -27.46% The SEC disclosed Today (18-AUG-2026) that SOLEUS CAPITAL MASTER FUND, L.P. has Newly bought 160,943 #PCSA shares Ownership: 5.8% * Estimated Investment Value: $387.87K https://www.thinksabio.com/reports/isr/PCSA Institutional ownership in #PCSA has been steadily rising over the past 9 quarters in Shares: Q2 2024: 1.80K Q3 2024: 1.94K Q4 2024: 3.96K Q1 2025: 6.83K Q2 2025: 14.90K Q3 2025: 71.59K Q4 2025: 115.17K Q1 2026: 177.71K Q2 2026: 255.55K Soleus Capital Master Fund, L.P. acquired 160,943 shares of PCSA, establishing a 5.8% ownership position in the healthcare company.